BR9711676A - M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose - Google Patents

M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose

Info

Publication number
BR9711676A
BR9711676A BR9711676A BR9711676A BR9711676A BR 9711676 A BR9711676 A BR 9711676A BR 9711676 A BR9711676 A BR 9711676A BR 9711676 A BR9711676 A BR 9711676A BR 9711676 A BR9711676 A BR 9711676A
Authority
BR
Brazil
Prior art keywords
post
treatment method
method including
including osteoporosis
menopausal disease
Prior art date
Application number
BR9711676A
Other languages
English (en)
Portuguese (pt)
Inventor
Jeremy N Bradbeer
Jacqueline Beeseley
Richard Bradbeer
Maxine Gowen
Original Assignee
Smithkline Beecha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecha Corp filed Critical Smithkline Beecha Corp
Publication of BR9711676A publication Critical patent/BR9711676A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9711676A 1996-09-06 1997-09-03 M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose BR9711676A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2543996P 1996-09-06 1996-09-06
US5066697P 1997-06-24 1997-06-24
PCT/US1997/015474 WO1998009519A1 (en) 1996-09-06 1997-09-03 Method of treating post menopausal diseases, including osteoporosis

Publications (1)

Publication Number Publication Date
BR9711676A true BR9711676A (pt) 1999-08-24

Family

ID=26699738

Family Applications (2)

Application Number Title Priority Date Filing Date
BR9711676A BR9711676A (pt) 1996-09-06 1997-09-03 M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose
BR9711681A BR9711681A (pt) 1996-09-06 1997-09-03 Novos m-todos

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR9711681A BR9711681A (pt) 1996-09-06 1997-09-03 Novos m-todos

Country Status (16)

Country Link
EP (2) EP0929216A4 (ja)
JP (2) JP2002515047A (ja)
KR (2) KR20000068473A (ja)
CN (2) CN1236313A (ja)
AR (1) AR008155A1 (ja)
AU (2) AU4247397A (ja)
BR (2) BR9711676A (ja)
CA (2) CA2264943A1 (ja)
CO (2) CO5070658A1 (ja)
CZ (1) CZ76699A3 (ja)
IL (1) IL128645A0 (ja)
NO (2) NO991096L (ja)
PL (2) PL332038A1 (ja)
TR (2) TR199900504T2 (ja)
TW (1) TW411273B (ja)
WO (2) WO1998009519A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998034608A1 (en) * 1997-02-11 1998-08-13 Novo Nordisk A/S Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) * 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
DE19905961A1 (de) * 1999-02-12 2000-08-17 Stefan Neubauer Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) * 2000-04-05 2003-03-04 Bristol-Meyers Squibb Pharma Company Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260066B1 (en) * 1986-09-11 1990-05-09 National Research Development Corporation Tamoxifen derivatives
HUT71244A (en) * 1992-09-15 1995-11-28 Merrell Dow Pharma Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
US5681835A (en) * 1994-04-25 1997-10-28 Glaxo Wellcome Inc. Non-steroidal ligands for the estrogen receptor
US5604248A (en) * 1994-05-05 1997-02-18 Eli Lilly And Company Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) * 1994-05-23 1995-11-28 Stromberg; Brent V. Method of treating peripheral vasoconstriction with tamoxifen citrate
AU6277396A (en) * 1995-06-07 1996-12-30 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis

Also Published As

Publication number Publication date
NO991097L (no) 1999-03-05
AU4409797A (en) 1998-03-26
BR9711681A (pt) 1999-08-24
WO1998009519A1 (en) 1998-03-12
CN1236299A (zh) 1999-11-24
CZ76699A3 (cs) 1999-08-11
WO1998009619A1 (en) 1998-03-12
NO991096D0 (no) 1999-03-05
TW411273B (en) 2000-11-11
JP2002515046A (ja) 2002-05-21
CN1236313A (zh) 1999-11-24
CO4920218A1 (es) 2000-05-29
CA2264943A1 (en) 1998-03-12
PL332038A1 (en) 1999-08-16
TR199900504T2 (xx) 1999-06-21
EP0929216A4 (en) 2001-04-04
EP0927029A4 (en) 2001-06-13
CA2264775A1 (en) 1998-03-12
AR008155A1 (es) 1999-12-09
IL128645A0 (en) 2000-01-31
PL332278A1 (en) 1999-08-30
KR20000068473A (ko) 2000-11-25
NO991096L (no) 1999-03-05
EP0929216A1 (en) 1999-07-21
TR199900506T2 (xx) 1999-07-21
CO5070658A1 (es) 2001-08-28
EP0927029A1 (en) 1999-07-07
JP2002515047A (ja) 2002-05-21
NO991097D0 (no) 1999-03-05
KR20000068472A (ko) 2000-11-25
AU4247397A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
IS4812A (is) Samsett meðferð fyrir beingisnun
DE59708166D1 (de) Röntgenaufnahme-Verfahren
SG50018A1 (en) Method for developing treatment
NO990531D0 (no) Partikkel-siktanordning
DE69730066D1 (de) Röntgenstrahlapparat
DE69724288D1 (de) Vorrichtung zum fusionieren von benachbarten knochenstrukturen
NO950275D0 (no) Kombinasjonsbehandling for osteoporose
DE69830863D1 (de) Röntgenaufnahmegerät
SG65673A1 (en) Developing method
DE69623437D1 (de) Wasserbehandlungsapparat
HK1042255A1 (zh) 廢物處理裝置
NO990449D0 (no) FremgangsmÕte for hydrogenbehandling
PT883718E (pt) Aparelho de dragagem
NO993019L (no) Elektrolyseapparat
GB9605828D0 (en) Treatment method
DE69735884D1 (de) Modemsteuerverfahren
BR9711676A (pt) M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose
DE69704054D1 (de) Modemsteuerungsverfahren
GB9714841D0 (en) Treatment method
ID16924A (id) Metode perlakuan poliolefin
FI972383A (fi) Osteoporoosihoitojaksoon tarkoitettu pakkaus
GB9814785D0 (en) Waste treatment method
ATE366573T1 (de) Neue behandlungsmethode
GB0009679D0 (en) Medical drainage apparatus
KR970053540U (ko) 침시술용 침관

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]